Precigen (PGEN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Precigen Revenue Highlights

Latest Revenue (Y)

$3.92M

Latest Revenue (Q)

$1.19M

Main Segment (Y)

Exemplar Segment

Main Geography (Y)

Non-US

Precigen Revenue by Period

Precigen Revenue by Year

Date	Revenue	Change
2024-12-31	$3.92M	-36.95%
2023-12-31	$6.22M	-76.87%
2022-12-31	$26.91M	-74.09%
2021-12-31	$103.87M	0.67%
2020-12-31	$103.18M	13.73%
2019-12-31	$90.72M	-43.50%
2018-12-31	$160.57M	-30.48%
2017-12-31	$230.98M	20.98%
2016-12-31	$190.93M	9.98%
2015-12-31	$173.60M	141.35%
2014-12-31	$71.93M	202.74%
2013-12-31	$23.76M	70.63%
2012-12-31	$13.93M	73.78%
2011-12-31	$8.01M	-

Precigen generated $3.92M in revenue during NA 2024, up -36.95% compared to the previous quarter, and up 4.33% compared to the same period a year ago.

Precigen Revenue by Quarter

Date	Revenue	Change
2024-12-31	$1.19M	24.87%
2024-09-30	$953.00K	32.91%
2024-06-30	$717.00K	-32.68%
2024-03-31	$1.06M	-13.27%
2023-12-31	$1.23M	-10.95%
2023-09-30	$1.38M	-21.96%
2023-06-30	$1.77M	-4.54%
2023-03-31	$1.85M	4.99%
2022-12-31	$1.76M	-89.46%
2022-09-30	$16.72M	474.44%
2022-06-30	$2.91M	-90.91%
2022-03-31	$32.02M	32.20%
2021-12-31	$24.22M	12.34%
2021-09-30	$21.56M	-35.79%
2021-06-30	$33.58M	37.00%
2021-03-31	$24.51M	26.78%
2020-12-31	$19.33M	-18.02%
2020-09-30	$23.58M	-22.49%
2020-06-30	$30.42M	1.96%
2020-03-31	$29.84M	75.50%
2019-12-31	$17.00M	-26.22%
2019-09-30	$23.04M	-35.97%
2019-06-30	$35.99M	54.21%
2019-03-31	$23.34M	-45.97%
2018-12-31	$43.19M	33.09%
2018-09-30	$32.45M	-28.33%
2018-06-30	$45.27M	3.27%
2018-03-31	$43.84M	-43.08%
2017-12-31	$77.03M	67.39%
2017-09-30	$46.02M	-15.46%
2017-06-30	$54.43M	1.28%
2017-03-31	$53.75M	16.84%
2016-12-31	$46.00M	-6.09%
2016-09-30	$48.98M	-6.70%
2016-06-30	$52.50M	20.86%
2016-03-31	$43.44M	4.67%
2015-12-31	$41.50M	-22.24%
2015-09-30	$53.37M	18.88%
2015-06-30	$44.89M	32.62%
2015-03-31	$33.85M	8.87%
2014-12-31	$31.09M	46.68%
2014-09-30	$21.20M	79.83%
2014-06-30	$11.79M	50.08%
2014-03-31	$7.85M	14.32%
2013-12-31	$6.87M	12.02%
2013-09-30	$6.13M	-9.56%
2013-06-30	$6.78M	70.55%
2013-03-31	$3.98M	-40.26%
2012-12-31	$6.66M	127.56%
2012-09-30	$2.92M	7.30%
2012-06-30	$2.73M	68.48%
2012-03-31	$1.62M	-

Precigen generated $1.19M in revenue during Q4 2024, up 24.87% compared to the previous quarter, and up 86.29% compared to the same period a year ago.

Precigen Revenue Breakdown

Precigen Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 22	Dec 21	Dec 20	Dec 19
Exemplar Segment	$3.92M	-	-	-	-
Upfront And Milestone Payments	-	$16.01M	$2.03M	$25.00M	$50.59M
Collaboration and licensing agreements	-	-	-	-	$2.17M

Precigen's latest annual revenue breakdown by segment (product or service), as of Dec 24: Exemplar Segment (100.00%).

Quarterly Revenue by Product

Product/Service	Mar 25	Dec 24	Sep 24	Jun 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Exemplar Segment	$1.06M	$2.25M	$953.00K	$717.00K	$1.38M	$1.77M	$1.85M	$1.65M	$2.10M	$2.84M	-	-	-	-	-	-	-	-	-	-
Biopharmaceuticals Segment	$1.34M	-	-	-	$116.00K	$14.62M	$70.00K	$367.00K	$1.27M	$503.00K	$419.00K	-	-	-	-	-	-	-	-	-
Reportable Segments	-	-	-	-	-	$1.77M	$1.85M	$1.76M	$16.72M	$2.91M	$33.61M	$24.49M	$22.83M	$33.76M	$24.86M	-	-	-	-	-
Trans Ova Segment	-	-	-	-	-	-	$1.85M	$20.64M	$18.35M	$29.86M	$21.18M	$15.41M	$15.28M	$23.93M	-	-	-	-	-	-
Other Segments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$624.00K	-
PGEN Therapeutics Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-467.00K	$2.16M	$1.83M	-	-
Human Biotherapeutics Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
MBP Titan Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Precigen ActoBio Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.00K	-	-
Collaboration and licensing agreements	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$100.00K	-
Upfront And Milestone Payments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$40.21M	-

Precigen's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Biopharmaceuticals Segment (55.74%), and Exemplar Segment (44.26%).

Precigen Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Non-US	$233.00K	$530.00K	$595.00K	$1.40M	$11.95M

Precigen's latest annual revenue breakdown by geography, as of Dec 22: Non-US (100.00%).

Quarterly Revenue by Country

Country	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Non-US	$16.00K	$63.00K	$70.00K	$205.00K	$87.00K	$93.00K	$251.00K	$99.00K	$114.00K	$118.00K	$122.00K	$241.00K	$3.33M	$2.19M	$2.27M	$1.56M	$2.23M	$3.95M	$4.43M

Precigen's latest quarterly revenue breakdown by geography, as of Dec 22: Non-US (100.00%).

Precigen Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
MRKR	Marker Therapeutics	$6.59T	$349.10K
CRMD	CorMedix	$43.47B	$31.21M
ADAP	Adaptimmune Therapeutics	$178.03M	$7.29M
DAWN	Day One Biopharmaceuticals	$131.16M	$29.21M
AGEN	Agenus	$103.46M	$24.07M
ZNTL	Zentalis Pharmaceuticals	$67.42M	$26.86M
SGMO	Sangamo Therapeutics	$57.80M	$6.44M
SNDX	Syndax Pharmaceuticals	$23.68M	$20.04M
AFMD	Affimed	$8.28M	$155.00K
PGEN	Precigen	$3.92M	$1.19M
IMMP	Immutep	$3.51M	$2.11M
CRVS	Corvus Pharmaceuticals	-	-
APTO	Aptose Biosciences	-	-
PTGX	Protagonist Therapeutics	-	$170.64M
EWTX	Edgewise Therapeutics	-	-
INZY	Inozyme Pharma	-	-
LPTX	Leap Therapeutics	-	-

PGEN Revenue FAQ

What is Precigen’s yearly revenue?

Precigen's yearly revenue for 2024 was $3.92M, representing a decrease of -36.95% compared to 2023. The company's yearly revenue for 2023 was $6.22M, representing a decrease of -76.87% compared to 2022. PGEN's yearly revenue for 2022 was $26.91M, representing a decrease of -74.09% compared to 2021.

What is Precigen’s quarterly revenue?

Precigen's quarterly revenue for Q4 2024 was $1.19M, a 24.87% increase from the previous quarter (Q3 2024), and a -3.09% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $953K, a 32.91% increase from the previous quarter (Q2 2024), and a -30.89% decrease year-over-year (Q3 2023). PGEN's quarterly revenue for Q2 2024 was $717K, a -32.68% decrease from the previous quarter (Q1 2024), and a -59.42% decrease year-over-year (Q2 2023).

What is Precigen’s revenue growth rate?

Precigen's revenue growth rate for the last 3 years (2022-2024) was -85.41%, and for the last 5 years (2020-2024) was -96.20%.

What are Precigen’s revenue streams?

Precigen's revenue streams in c 24 are Exemplar Segment

What is Precigen’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Precigen was Exemplar Segment. This segment made a revenue of $3.92M, representing 100.00% of the company's total revenue.